Skip to search formSkip to main contentSkip to account menu

MTP 1307

Known as: 6H-Thiopyrano(3,2-d)pyrimidine, 7,8-dihydro-2-(4-methyl-1-piperazinyl)-4-(1-pyrrolidinyl)-, (Z)-2-butenedioate (1:2), MTP-1307 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pyrimidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Antidiabetic activity of MTP-3115 in normal and diabetic mice.
MTP-3115 is a newly-synthesized thiopyranopyrimidine compound with a structure similar to that of MTP-1403 and MTP-1307. However… 
1989
1989
Pharmacological studies on the hypoglycemic effect of 7,8-dihydro-2-(4-methylpiperazinyl)-4-(1-pyrrolidinyl)-6H-thi opyrano [3,2-d] pyrimidine dimaleate (MTP-1307), a novel hypoglycemic agent.
MTP-1307, 7,8-dihydro-2-(4-methylpiperazinyl)-4-(1-pyrrolidinyl)-6H- thiopyrano[3,2-d]pyrimidine dimaleate, is a novel oral… 
1987
1987
MTP-1307, a novel antidiabetic agent, improves the glucose intolerance of viable yellow obese-diabetic mice.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)